abstract |
The subject of the present invention is a compound of formula (I) in the form of a base, a hydrate or a solvate, or a mixture thereof. As a pharmaceutical, or for the manufacture of a medicament for the treatment and / or prevention of disorders associated with the central nervous system (abbreviated CNS) and / or peripheral nervous system (abbreviated SNP). . |